5 results match your criteria: "Department of Respiratory Medicine Middlemore Hospital[Affiliation]"
Respirol Case Rep
June 2022
Department of Respiratory Medicine North Shore Hospital, Waitematā District Health Board Auckland New Zealand.
Pulmonary mucormycosis (PM) is a rare but rapidly progressive fungal infection associated with high mortality. A review of the literature suggests that pleural effusions and pneumothoraces are uncommon manifestations associated with distant dissemination. Combined surgical interventions and prolonged antifungal therapy constitute the standard first-line management, with significantly poorer outcomes seen in patients managed with medical therapy alone.
View Article and Find Full Text PDFHealth Sci Rep
December 2020
Department of Respiratory Medicine Middlemore Hospital, Counties Manukau District Health Board Auckland New Zealand.
Respirol Case Rep
August 2020
Department of Respiratory Medicine Middlemore Hospital, Counties Manukau DHB Auckland New Zealand.
Hypertrophic pulmonary osteoarthropathy (HPOA) is a well-documented complication of pulmonary malignancy and cystic fibrosis (CF). However, HPOA associated with exacerbations of non-CF bronchiectasis has only been reported once previously in an adolescent. We describe a case of an adult patient with bronchiectasis and HPOA, whose joint symptoms flared during pulmonary exacerbations and improved with treatment of each exacerbation.
View Article and Find Full Text PDFInfection remains a significant problem for patients with cardiac-implantable electronic devices (CIEDs) but can be difficult to diagnose. We describe an unusual presentation of CIED infection in a patient with abandoned pacemaker leads. A 27-year-old male presented with facial flushing on upper but not lower limb exertion due to superior vena cava (SVC) obstruction, as well as pleuritic chest pain due to septic emboli.
View Article and Find Full Text PDFIn diagnosing peripheral pulmonary lesions (PPL), radial endobronchial ultrasound (R-EBUS) is emerging as a safer method in comparison to CT-guided biopsy. Despite the better safety profile, the yield of R-EBUS remains lower (73%) than CT-guided biopsy (90%) due to the smaller size of samples. We adopted a hybrid method by adding cryobiopsy via the R-EBUS Guide Sheath (GS) to produce larger, non-crushed samples to improve diagnostic capability and enhance molecular testing.
View Article and Find Full Text PDF